LNBeta 2.5mg Tablet 15's

LNBeta 2.5mg Tablet 15's

Prescription drug
Manufacturer / Marketer : ERIS ADURA
About: LNBeta 2.5mg Tablet 15's is an oral anti‑diabetic combination medicine containing linagliptin and metformin, used for managing blood glucose in adults with type 2 diabetes mellitus.[]
Usage Instructions: Take the tablet with food as advised by the doctor, usually once or twice daily depending on strength and regimen.
Benefits: Helps control fasting and post‑prandial blood sugar levels, and may aid in reducing long‑term diabetes complications when used with lifestyle measures.[]
How it Works: Metformin lowers hepatic glucose production and improves peripheral insulin sensitivity, while linagliptin, a DPP‑4 inhibitor, increases incretin levels to boost insulin release and reduce glucagon.[]
Side Effects: Gastrointestinal symptoms, headache, or upper respiratory infections may occur; the risk of hypoglycaemia is generally low when used alone.
Safety Advice: Contraindicated in severe renal impairment or diabetic ketoacidosis; periodic monitoring of kidney function and blood glucose is recommended.[]
Storage: Store at room temperature below 25°C, away from moisture and direct sunlight.
₹208.91 MRP: ₹232.12 Save ₹23.21 (9%)
Inclusive of all taxes
Quantity

Expiry Icon
Fresh Stock
Guaranteed
Return Icon
Secure & Hygienic
Packaging
Authentic Icon
Verified & Trusted
Supplements
Quality Icon
Secure
Payment
About: LNBeta 2.5mg Tablet 15's is an oral anti‑diabetic combination medicine containing linagliptin and metformin, used for managing blood glucose in adults with type 2 diabetes mellitus.[]
Usage Instructions: Take the tablet with food as advised by the doctor, usually once or twice daily depending on strength and regimen.
Benefits: Helps control fasting and post‑prandial blood sugar levels, and may aid in reducing long‑term diabetes complications when used with lifestyle measures.[]
How it Works: Metformin lowers hepatic glucose production and improves peripheral insulin sensitivity, while linagliptin, a DPP‑4 inhibitor, increases incretin levels to boost insulin release and reduce glucagon.[]
Side Effects: Gastrointestinal symptoms, headache, or upper respiratory infections may occur; the risk of hypoglycaemia is generally low when used alone.
Safety Advice: Contraindicated in severe renal impairment or diabetic ketoacidosis; periodic monitoring of kidney function and blood glucose is recommended.[]
Storage: Store at room temperature below 25°C, away from moisture and direct sunlight.

Related Products